Skip to main content
logo
Charming Medical Limited (MCTA)
NASDAQ: MCTA · Real-Time Price · USD
29.11
-0.25 (-0.83%)
Nov 11, 2025, 4:00 PM EDT - Market closed

Charming Medical Financials Overview

Millions USD. Fiscal year is Apr - Mar.

Revenue & Profits
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23
Revenue
4.814.816.226.023.53
Revenue Growth
-11.35%-22.73%3.43%70.37%-
Gross Profit
4.774.776.2163.51
Operating Income
-0.03-0.031.391.01-0.52
Net Income
-0.02-0.021.20.78-0.31
Earnings Per Share
--0.080.05-0.02
EPS Growth
--60.00%--

Cash & Debt
Chart
Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23
Cash & Investments
6.546.542.762.11.93
Total Debt
0.910.911.160.961.81
Net Cash (Debt)
5.635.631.61.140.12
Net Cash Growth
166.36%251.62%40.13%854.46%-
Net Cash Per Share
0.350.350.100.000.00

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23
Operating Cash Flow
-1.22-1.220.430.32.43
Capital Expenditures
-0.34-0.34-0.29-0.21-0.61
Free Cash Flow
-1.56-1.560.140.081.83
Free Cash Flow Growth
--63.10%-95.36%-

Margins
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23
Gross Margin
99.27%99.27%99.75%99.81%99.51%
Operating Margin
-0.61%-0.61%22.32%16.77%-14.77%
Pretax Margin
2.78%2.78%23.07%16.68%-11.91%
Profit Margin
-0.47%-0.47%19.27%13.66%-9.51%
FCF Margin
-32.35%-32.35%2.22%1.41%51.76%

Valuation
Chart
Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023
Period EndingAug '26 Mar '26 Mar '25 Mar '24 Mar '23
PS Ratio
104.89104.89---